QURE

uniQure N.V.

1QURE
NLD
NASDAQ

$4.57

24H

Market Cap

221.9 M

Volume

397.6 K

Supply

48.5 M

Price Chart

About uniQure N.V. - QURE

uniQure N.V. is a biotechnology company known for its pioneering work in gene therapy, utilizing adeno-associated virus (AAV) vectors to deliver therapeutic genes to target cells. Their research and development focus on severe genetic diseases, including hemophilia and neurological disorders.

What are uniQure N.V.'s core values and mission statement?

uniQure N.V. is committed to delivering on the promise of gene therapy - single treatments with potentially curative results. They aim to provide patients with life-changing therapies to combat genetic diseases.

Who founded uniQure N.V. and when?

uniQure N.V. was founded by a team including Sander van Deventer among others, and the company was established in 1998.

Who leads uniQure N.V.?

As of the last update available, Matt Kapusta is the Chief Executive Officer (CEO) at uniQure N.V.

Where is uniQure N.V. located, and what is its base country?

uniQure N.V. is headquartered in Amsterdam, the Netherlands, which is its base country.

On which exchanges is uniQure N.V. traded?

uniQure N.V. is traded on the Nasdaq Stock Market under the ticker symbol QURE.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open/Close
Low/High
Volume
Cap

uniQure N.V. (QURE) Price Live Data

The live price of uniQure N.V. (QURE) is $4.57, with a trading volume of 397,613 in the last 24 hours. Wrapstocks updates the QURE price in real-time. uniQure N.V. is up 0% in the last 24 hours. The company has a live market cap of $221,870,768.00 and a supply of 48,549,402 QURE stocks.

uniQure N.V. (QURE) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 11 hours and 51 minutes.

Exchange
NASDAQ
NASDAQ
NASDAQ Stock Exchange
USA
Opens in
11 hours and 51 minutes
Working Hours
Mon-Fri, 01:30 PM - 08:00 PM
Timezone
GMT+0
Last Updated
20 Jun 2024 07:56 PM